Lenti-entry-puro Citations (1)
Originally described in: An easy and efficient inducible CRISPR/Cas9 platform with improved specificity for multiple gene targeting.Cao J, Wu L, Zhang SM, Lu M, Cheung WK, Cai W, Gale M, Xu Q, Yan Q Nucleic Acids Res. 2016 Nov 2;44(19):e149. Epub 2016 Jul 25. PubMed Journal
Articles Citing Lenti-entry-puro
| Articles |
|---|
| CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy. Jiang L, Liang J, Huang W, Ma J, Park KH, Wu Z, Chen P, Zhu H, Ma JJ, Cai W, Paul C, Niu L, Fan GC, Wang HS, Kanisicak O, Xu M, Wang Y. Mol Ther. 2022 Jan 5;30(1):54-74. doi: 10.1016/j.ymthe.2021.10.015. Epub 2021 Oct 20. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.